Lipitor may hold the throne as the world’s top selling prescription of all time, but recently some studies have shown that the drug could be linked to serious adverse effects including Type 2 Diabetes.
Lipitor is a cholesterol-lowering medication that has been around since 1996. It was originally marketed by Warner Lambert company and was later acquired by Pfizer who obtained all the rights of the drug.
Lipitor belongs to HMG CoA reductase inhibitors class of drug, or “statins” as it is known as to consumers. The drug is used in adults and children who are not less than 10 years old to treat high cholesterol. Lipitor was designed to lower the risk of heart problems, stroke and type 2 diabetes.
Prior to the drug’s loss of patent protection last 2011 (before the drug became generic in the market) it was able to generate $13 billion for the manufacturer, the pharmaceutical giant, Pfizer, Inc.
Lipitor is linked to a few serious adverse effects including kidney and liver damages and Type 2 diabetes in post-menopausal women. In 2012, the Food and Drug Administration ordered the manufacturer to add warning to Lipitor’s label that must cite the new-onset diabetes. Those who are affected by Lipitor’s adverse effects are advised to seek legal advice from a lawyer.
During the first half of 2014, Lipitor lawsuits filed by women who were stricken by the side effects of the drug soared up to almost a thousand from 56. This led the federal judicial panel to consolidate the cases and put it into a single federal court in South Carolina.